A recent study published in the Journal of the American College of Cardiology analysed 18,500 men with stable coronary artery disease who were being treated for impotence. Out of these, 16,500 were on Viagra and 2,000 were receiving alprostadil, another drug to treat erectile dysfunction but administered through a syringe.